Kinaset Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, focused on developing novel therapeutics.
Subscribe to see Kinaset Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kinaset Therapeutics, Inc. is a biotechnology company headquartered in Medfield, United States. Its most recent funding round, Series B, raised $103M in January 2026. Xcout tracks 15 named people at Kinaset Therapeutics, Inc., including Robert Clarke (Chief Executive Officer / Board Member / Co-Founder).
As of 16 November 2026. Source: Xcout Intel.
9 more named people on record for Kinaset Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $103M | 11 named | |
| SEC Form D filing | $28.5M | — | |
| — | $40M | 11 named | |
| SEC Form D filing | $1.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 11 named investors across 2 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of Kinaset Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
KinoPharma, Inc. is a clinical-stage biopharmaceutical company headquartered in Tokyo, Japan. The company focuses on researching and developing innovative small-molecule drugs based on novel concepts to address major medical needs, such as antiviral treatments.
Ratio Therapeutics is a clinical-stage pharmaceutical company headquartered in Boston, Massachusetts. The company employs a suite of innovative technologies for the discovery and early clinical development of targeted radiopharmaceuticals.
Pretzel Therapeutics is a biotechnology company headquartered in Boston, Massachusetts, advancing a new class of medicines that target cellular energetics and mitochondrial function.
Centessa Pharmaceuticals LLC is a biotechnology research company headquartered in Boston, Massachusetts, United States. The company comprises leaders, innovators, and scientists dedicated to pursuing and developing transformational medicines for patients.
FogPharma, also known as Parabilis Medicines, is a clinical-stage biopharmaceutical and biotechnology research company headquartered in Cambridge, Massachusetts. The company is dedicated to creating novel therapeutics.
NextPoint Therapeutics is a private biopharmaceutical and technology company based in Cambridge, Massachusetts, focused on expanding novel therapeutic possibilities.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Kinaset Therapeutics, Inc.? Suggest a correction · Work at Kinaset Therapeutics, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.